14 Nov 2008

BD: High-Content Imaging-Emit More Data!
Mindy Goldsborough
Director, Cell Biology R&D, BD Biosciences - Bioimaging Systems

High-content imaging is an automated process that begins with image acquisition and concludes with data analysis. Its power resides in the ability to measure not only fluorescence intensity changes, but also temporal and spatial dynamics. High-content imaging also enables multiplexed assays that simultaneously measure and analyze several cellular parameters. However, multiplexing is often restricted due to reagent, assay, and instrumentation limitations. BD Biosciences is addressing this by developing specific instrumentation, assays, reagents, and software that enable multiplexing. We will highlight the capabilities of the BD Pathway™, such as kinetic and confocal imaging, and the impact these features have on high-content imaging. In particular, we will address several challenging applications including stem cells and neurobiology. In addition, we will discuss the development of a line of BD™ Bioimaging Certified reagents that have direct impact on the ability to multiplex.

Speaker’s biography:

Dr Goldsborough received her Ph.D from The George Washington University in Washington, D.C. She has held positions of increasing responsibility at The NIH National Cancer Institute, Life Technologies, Invitrogen and currently at BD Biosciences. Dr Goldsborough has made contributions to science in the areas of Oncology, Forensics, Stem Cell Biology, Genomics and Imaging. She is currently the Director of Cell Biology R&D at BD Biosciences - Bioimaging Systems.

For more details, please contact gisv2@gis.a-star.edu.sg